Sotera Health (NASDAQ:SHC) Given Average Rating of “Moderate Buy” by Analysts

Shares of Sotera Health (NASDAQ:SHC) have earned an average rating of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $15.70.

Several research firms recently weighed in on SHC. Barclays increased their price target on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Royal Bank of Canada restated an “outperform” rating and issued a $17.00 target price on shares of Sotera Health in a report on Tuesday, August 6th.

Insider Activity

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the transaction, the director now directly owns 49,215,301 shares in the company, valued at $739,705,974.03. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 55.12% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. CWM LLC lifted its position in Sotera Health by 86.1% during the second quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after acquiring an additional 993 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Sotera Health by 125.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after acquiring an additional 1,660 shares during the period. Point72 DIFC Ltd increased its stake in shares of Sotera Health by 556.6% in the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after purchasing an additional 5,544 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Sotera Health by 728.0% in the 2nd quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after purchasing an additional 8,248 shares during the period. Finally, Sandia Investment Management LP purchased a new position in Sotera Health during the first quarter worth approximately $120,000. Institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Down 0.3 %

SHC stock opened at $15.46 on Friday. The company has a debt-to-equity ratio of 5.46, a current ratio of 2.93 and a quick ratio of 2.59. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44. The business has a 50 day simple moving average of $15.86 and a two-hundred day simple moving average of $13.37. The company has a market capitalization of $4.38 billion, a price-to-earnings ratio of 110.43 and a beta of 2.07.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Monday, August 5th. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The company had revenue of $277.00 million during the quarter, compared to analyst estimates of $266.45 million. During the same period in the prior year, the company earned $0.19 earnings per share. The firm’s revenue was up 8.6% on a year-over-year basis. Research analysts anticipate that Sotera Health will post 0.64 EPS for the current fiscal year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.